Renaissance
Renaissance Lakewood is a US-based pure-play CDMO that develops and manufactures nasal spray and sterile injectable drug products for pharmaceutical and biotech clients, from formulation through commercial manufacturing, operating 370,000+ sq ft of cGMP capacity in New Jersey.
- Company typePrivate
- Founded1979
- HeadquartersLakewood, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Renaissance does
Renaissance Lakewood, LLC is a US-based, pure-play contract development and manufacturing organization (CDMO) that develops and manufactures nasal spray and sterile injectable drug products on behalf of pharmaceutical and biotech clients. The company was founded in 1979 in Lakewood, New Jersey, and operated as DPT Lakewood until a 2012 acquisition by RoundTable Healthcare Partners, followed by a 2016 divestiture of its dermatologic business to Mylan and a rebrand to Renaissance Lakewood as a focused nasal and sterile CDMO. Renaissance was acquired by LTS LOHMANN Therapie-Systeme AG in November 2025.
The company's core technology is aseptic fill-finish manufacturing for nasal sprays and sterile injectable dosage forms, executed in cGMP-compliant ISO5/Class A environments using RABS technology, 0.22 micron filtration, and inline quality inspection systems with 14 integrated checks. It operates 10+ cGMP manufacturing suites supporting unit-dose, bi-dose, and multi-dose preserved nasal sprays as well as sterile vials, with a high-speed assembly line capable of 200 units per minute. Supporting capabilities include one of the world's largest spray characterization laboratories (expanded to roughly 3x its original size), formulation R&D, analytical method development, and secondary packaging. The campus footprint totals 370,000+ sq ft across multiple buildings in Lakewood, NJ, with additional capacity under construction.
Renaissance serves pharmaceutical and biotech companies on a project-based, multi-year contract basis, taking clients from formulation development through clinical and commercial manufacturing. Pricing is negotiated per project rather than published. The go-to-market is sales-led via direct enterprise engagement, supplemented by industry conference participation (e.g., DDL 2025 in Edinburgh) and content marketing. Customers are unnamed pharmaceutical and biotech enterprises ranging from emerging biotech to established pharma. Renaissance is differentiated by its narrow focus on nasal sprays and sterile injectables, 20+ years of domain experience, validated regulatory track record including the first FDA-approved bi-dose nasal spray, and capital-intensive specialized infrastructure.
Renaissance firmographics
Firmographics- Name
- Renaissance
- Legal name
- Renaissance Lakewood, LLC
- Website
- https://renpharm.com
- Company type
- Private
- Founded year
- 1979
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Renaissance Lakewood is a US-based pure-play CDMO that develops and manufactures nasal spray and sterile injectable drug products for pharmaceutical and biotech clients, from formulation through commercial manufacturing, operating 370,000+ sq ft of cGMP capacity in New Jersey.
- Ownership category
- akta.pro rank
Renaissance industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing (CDMO)
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
- akta.pro secondary industry
- Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)
Keywords
Where Renaissance is headquartered
LocationHeadquarters
- HQ city
- Lakewood
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Renaissance business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Development and Manufacturing Services: Renaissance generates revenue by providing contract development and manufacturing services to pharmaceutical and biotech companies. Services include formulation development, analytical development, spray characterization, aseptic fill-finish manufacturing, and secondary packaging for nasal sprays and sterile injectable dosage forms. Revenue is project-based, typically structured as long-term contracts from early clinical stages through commercial launch.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based contract services for pharmaceutical development and manufacturing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Renaissance product offering
Product offeringCore offering
Renaissance Lakewood is a pure-play contract development and manufacturing organization (CDMO) that develops and manufactures nasal spray and sterile injectable drug products for pharmaceutical and biotech companies. The company provides an integrated bench-to-shelf service offering spanning formulation development, analytical method development, spray characterization, aseptic fill-finish manufacturing, clinical and commercial manufacturing, and secondary packaging for unit-dose, bi-dose, and multi-dose nasal sprays as well as sterile injectables.
Differentiator
Problem solved
Functional benefit
Products and services
- Nasal Spray Manufacturing Contract manufacturing of nasal spray drug products across unit-dose, bi-dose, and multi-dose configurations, with multiple aseptic fill-finish lines supporting GMP material from development scale through high-throughput commercial production for pharmaceutical and biotech clients.
- Aseptic Filling (Sterile Injectable Manufacturing) Aseptic fill-finish contract manufacturing services for sterile vials and injectable dosage forms, utilizing ISO5/Class A filling environments, RABS technology, and 0.22 micron filtration, supporting clinical through commercial volumes for pharmaceutical and biotech clients.
- Pharmaceutical Research & Development Pre-formulation and formulation development services, analytical method development, spray characterization, and research & development support for nasal spray and sterile injectable drug products, spanning early development through validation.
- Nasal Spray Testing Services Chemistry, microbiology, and spray testing services supporting development and validation of analytical methods, as well as release and stability testing of finished nasal spray products. Includes spray pattern analysis, particulate testing, and quality control testing.
- Pharmaceutical Packaging Services Secondary packaging services for nasal spray and injectable drug products including labeling, blister packaging, cartoning, serialization, and case packing with inline quality inspection systems.
Quantifiable outcome
- First manufacturer of the first FDA approved bi-dose nasal spray drug
- +3 more outcomes
Companies that use Renaissance
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Renaissance technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Renaissance partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- LTS LOHMANN Therapie-Systeme AGcoreLTS LOHMANN Therapie-Systeme AG, a German pharmaceutical technology company, acquired Renaissance Lakewood, LLC. The acquisition integrates Renaissance's nasal spray and sterile dosage form manufacturing capabilities into LTS's global network, which includes facilities in Andernach, Germany, West Caldwell NJ, St. Paul MN, and Netanya, Israel. The transaction closed in November 2025, pending regulatory approval.
- Raven ConsultingminorRenaissance partnered with Raven consulting on continuous improvement of its manufacturing processes. Raven's digital OEE (Overall Equipment Effectiveness) improvement software was integrated into Renaissance's manufacturing lines to drive operator engagement, real-time visibility, and data-led productivity improvements.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
Renaissance competitors and assessment
Company assessmentDirect peers
- Hovione: Hovione is a CDMO offering particle engineering, API manufacturing, and aseptic fill-finish services with strong inhalation and nasal drug delivery expertise. It directly overlaps with Renaissance on nasal spray formulation, particle engineering, and sterile manufacturing.
- Vetter Pharma: Vetter Pharma is a German CDMO specializing in aseptic fill-finish for injectable drug products including syringes, vials, and cartridges. It is highly comparable to Renaissance in sterile injectable operations though narrower in nasal spray capability.
- West Pharmaceutical Services: West Pharmaceutical Services supplies elastomeric components and drug delivery systems for injectable and nasal drug-device combination products. It overlaps with Renaissance on sterile elastomer/container delivery and integrated device-component manufacturing for injectable and intranasal formats.
- Aptar Pharma: Aptar Pharma is the drug delivery division of AptarGroup, providing nasal spray pumps, valves, and devices with integrated contract manufacturing services. It directly competes with Renaissance in nasal spray device assembly and fill-finish for unit-dose, bi-dose, and multi-dose formats, making it the most comparable peer.
Broad incumbents
- Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher Scientific's pharma services network, provides large-scale sterile fill-finish, oral solid dose, and API manufacturing. It competes with Renaissance for commercial-scale aseptic fill-finish contracts though it is not specialized in nasal sprays.
- Siegfried Holding: Siegfried Holding is a Swiss CDMO providing API manufacturing and sterile fill-finish services for injectable and nasal drug products. It competes with Renaissance on commercial-scale sterile manufacturing though API-focused in its core positioning.
- Recipharm: Recipharm is a European CDMO providing sterile fill-finish, oral solids, and semi-solids manufacturing. It competes with Renaissance on aseptic injectable fill-finish programs though with broader dosage form scope and a European footprint.
- Aenova Group: Aenova is a German CDMO providing solid, semi-solid, sterile liquid, and API manufacturing. Its sterile liquid capabilities overlap with Renaissance's aseptic fill-finish services though Aenova serves a broader range of dosage forms.
- Catalent: Catalent is a global CDMO offering softgel, biologics, oral, and sterile fill-finish services across multiple dosage forms. It competes with Renaissance in sterile nasal/injectable fill-finish but serves a much broader sponsor base across diverse drug delivery modalities.
Emerging players
- Becton Dickinson (BD) Pharmaceutical Systems: BD Pharmaceutical Systems manufactures drug delivery devices and prefillable systems for injectables and intranasal delivery. It participates in the nasal and injectable delivery infrastructure layer that supports nasal spray drug-device combination products comparable to Renaissance's manufacturing focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Renaissance social profiles
Digital presenceRenaissance financial estimates
Financial estimateRevenue estimate
Valuation estimate
Renaissance leadership team
Management profileNumber of profiles
Profiles4 records
Renaissance funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Renaissance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Renaissance
What does Renaissance do?
Renaissance Lakewood is a pure-play contract development and manufacturing organization (CDMO) that develops and manufactures nasal spray and sterile injectable drug products for pharmaceutical and biotech companies. The company provides an integrated bench-to-shelf service offering spanning formulation development, analytical method development, spray characterization, aseptic fill-finish manufacturing, clinical and commercial manufacturing, and secondary packaging for unit-dose, bi-dose, and multi-dose nasal sprays as well as sterile injectables.
Is Renaissance a public or private company?
Renaissance is a private company. It is classified as corporate owned and is currently acquired.
When was Renaissance founded?
Renaissance was founded in 1979. It employs 251 to 500 people.
Where is Renaissance based?
Renaissance is headquartered in Lakewood, United States, in the North America region.
How does Renaissance make money?
One revenue line is on record: contract Development and Manufacturing Services.
Who are Renaissance's main competitors?
Direct peers on record are Hovione, Vetter Pharma, West Pharmaceutical Services and Aptar Pharma. Broad incumbents are Patheon (Thermo Fisher Scientific), Siegfried Holding, Recipharm, Aenova Group and Catalent. Becton Dickinson (BD) Pharmaceutical Systems is listed as an emerging player.
Does Renaissance have an API?
No public API is recorded for Renaissance.
What industry is Renaissance in?
Renaissance's product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 3254 and its SIC code is 2833.